<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00683956</url>
  </required_header>
  <id_info>
    <org_study_id>SU-05062008-1141</org_study_id>
    <secondary_id>13305</secondary_id>
    <nct_id>NCT00683956</nct_id>
  </id_info>
  <brief_title>Evaluation of a Closed-Loop Control System for Administering Patient-Specific Anesthesia</brief_title>
  <official_title>Evaluation of a Closed-Loop Control System for Patient-Specific Induction and Maintenance of Propofol Hypnosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <brief_summary>
    <textblock>
      Numerous efforts have focused on the development of closed-loop systems to control anesthesia&#xD;
      using the electrical activity of the brain (EEG) and EEG-based parameters as surrogate&#xD;
      measures of anesthetic depth. New systems have been recently developed to considerably&#xD;
      improve anesthetic control using model-based, patient-adaptive methods. The purpose of this&#xD;
      study is to evaluate the clinical efficacy of a new intelligent software, ReinLoop, in&#xD;
      delivering closed-loop, patient-specific hypnosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the clinical efficacy of the ReinLoop agent in delivering closed-loop, patient-specific hypnosis.</measure>
  </primary_outcome>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Anesthesia, General</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReinLoop control software for patient-specific induction and maintenance of anesthesia</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. 18-45 years of age&#xD;
&#xD;
          2. Body mass index (BMI) lower or equal to 25 m2/kg&#xD;
&#xD;
          3. Subjects must be able to comprehend spoken and written English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Any type of psychiatric, neurological, or neuromuscular disorder&#xD;
&#xD;
          2. Thyroid disease&#xD;
&#xD;
          3. History of smoking&#xD;
&#xD;
          4. Alcohol consumption which exceeds 2 drinks per day and /or drug abuse. Volunteers will&#xD;
             be asked the question: How many drinks are you drinking on your typical day?&#xD;
&#xD;
          5. Allergy to study medication (propofol), soy, or egg proteins.&#xD;
&#xD;
          6. History of drug abuse&#xD;
&#xD;
          7. Chronic or acute use of opioids, or other medications affecting the CNS&#xD;
&#xD;
          8. Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anthony Doufas</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <study_first_submitted>May 22, 2008</study_first_submitted>
  <study_first_submitted_qc>May 22, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2008</study_first_posted>
  <last_update_submitted>November 22, 2011</last_update_submitted>
  <last_update_submitted_qc>November 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

